HPV And Cervical Cancer: Advances In Prevention And Management

فيروس الورم الحليمي البشري وسرطان عنق الرحم: التطوّرات في الوقاية والعلاج

The third webinar of the 2025 first-quarter series, HPV and Cervical Cancer: Advances in Prevention and Management, was held on Tuesday, April 8, 2025. Organized under the tripartite partnership between the Ministry of Public Health (MoPH), the Australian Lebanese Medical Association (ALMA), and the International Organization for Migration (IOM), this session hosted two distinguished guest speakers that explored the latest medical and health advancements on HPV and cervical cancer, with a comparative perspective between Australia and Lebanon to reflect on global applications.

If you missed the live session, you could still watch it here: https://www.youtube.com/watch?v=VBJpp52bgsc

The second quarter of the series is coming back soon, so stay tuned for more details on the Ministry’s social media pages!

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
H01CB02	SANDOSTATIN	B	Octreotide - 0.1mg/ml	0.1mg/ml	Injectable solution	1,038,790 L.L
D10AX03	SKINOREN	B	Azelaic acid - 0.2g/g	0.2g/g	Cream	722,987 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.375mg	0.375mg	Tablet, extended release	473,033 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.3mg/ml	0.3mg/ml	Injectable solution	175,400,801 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	133,856 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	163,184 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	176,974 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	161,805 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	144,797 L.L
B05XA03	SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	161,314 L.L
B05XA03	SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L
B05XA03	SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	148,566 L.L
B05XA03	SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	158,587 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	176,974 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	18,264,981 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	17,079,643 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.6mg/ml	0.6mg/ml	Injectable solution	187,497,407 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.75mg	0.75mg	Tablet, extended release	942,034 L.L
N04BC05	SIFROL	B	Pramipexole (dihydrochloride monohydrate) - 0.7mg	0.7mg	Tablet	2,478,046 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	156,288 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	165,482 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	176,974 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	163,184 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	156,288 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	4,143,943 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	3,985,356 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	5,566,628 L.L

...